|
Case Name |
Date Filed |
Judge |
Drug |
Patent |
|
Alpex Pharma., S.A. v. Zydus Pharma. USA, Inc., 13-4076 (D.N.J.) |
July 1, 2013 |
Hon. Noel L. Hillman |
Suprenza®(phentermine hydrochloride tablets) |
6,149,938 |
|
Purdue Pharma L.P. v. Teva Pharma. USA, Inc., 13-4606 (S.D.N.Y.) |
July 2, 2013 |
Hon. Sidney H. Stein |
OxyContin®(oxycodone hydrochloride) |
8,337,888 8,309,060 |
|
Novartis AG v. Accord Healthcare, Inc. USA, 13-1013 (D.D.C.) |
July 3, 2013 |
Hon. Emmet G. Sullivan |
Myfortic®(mycophenolate sodium delayed-release tablets) |
6,025,391 6,172,107 6,306,900 |
|
Aptalis Pharma US Inc. v. Mylan Pharma., Inc., 13-4158 (D.N.J.) |
July 5, 2013 |
Hon. Mary L. Cooper |
Canasa®(mesalamine rectal suppository) |
8,217,083 8,436,051 |
|
Apotex Corp. v. Alcon Research Ltd., IPR2013-00428 (PTAB) |
July 5, 2013 |
N/A |
Travatan Z®(travoprost ophthalmic solution) |
8,268,299 |
|
Apotex Corp. v. Alcon Research Ltd., IPR2013-00429 (PTAB) |
July 5, 2013 |
N/A |
Travatan Z®(travoprost ophthalmic solution) |
8,323,630 |
|
Apotex Corp. v. Alcon Research Ltd., IPR2013-00430 (PTAB) |
July 5, 2013 |
N/A |
Travatan Z®(travoprost ophthalmic solution) |
8,388,941 |
|
Par Pharma., Inc. v. Takeda Pharma. Co., Ltd., 13-3151 (N.D. Cal.) |
July 9, 2013 |
Hon. Elizabeth D. Laporte |
Dexilant®(dexlansoprazole delayed-release capsules) |
8,461,187 |
|
Brigham and Women’s Hospital, Inc. v. Perrigo Co., 13-11640 (D. Mass.) |
July 9, 2013 |
Hon. Rya W. Zobel |
Pepcid Complete®(famotidine / magnesium hydroxide / calcium carbonate tablets) |
5,229,137 |
|
UCB, Inc. v. Accord Healthcare, Inc., 13-1206 (D. Del.) |
July 10, 2013 |
Hon. Leonard P. Stark |
Vimpat®(lacosamide tablets) |
RE38,551 |
|
UCB, Inc. v. Alembic Pharma. Ltd., 13-1207 (D. Del.) |
July 10, 2013 |
Hon. Leonard P. Stark |
Vimpat®(lacosamide tablets) |
RE38,551 |
|
UCB, Inc. v. Amneal Pharma, LLC, 13-1208 (D. Del.) |
July 10, 2013 |
Hon. Leonard P. Stark |
Vimpat®(lacosamide tablets) |
RE38,551 |
|
UCB, Inc. v. Apotex Corp., 13-1209 (D. Del.) |
July 10, 2013 |
Hon. Leonard P. Stark |
Vimpat®(lacosamide tablets) |
RE38,551 |
|
UCB, Inc. v. Aurobindo Pharma Ltd., 13-1210 (D. Del.) |
July 10, 2013 |
Hon. Leonard P. Stark |
Vimpat®(lacosamide tablets) |
RE38,551 |
|
UCB, Inc. v. Breckenridge Pharma., Inc., 13-1211 (D. Del.) |
July 10, 2013 |
Hon. Leonard P. Stark |
Vimpat®(lacosamide tablets) |
RE38,551 |
|
UCB, Inc. v. Glenmark Generics Inc., USA., 13-1212 (D. Del.) |
July 10, 2013 |
Hon. Leonard P. Stark |
Vimpat®(lacosamide tablets) |
RE38,551 |
|
UCB, Inc. v. Hetero USA Inc., 13-1213 (D. Del.) |
July 10, 2013 |
Hon. Leonard P. Stark |
Vimpat®(lacosamide tablets) |
RE38,551 |
|
UCB, Inc. v. Mylan Pharma. Inc., 13-1214 (D. Del.) |
July 10, 2013 |
Hon. Leonard P. Stark |
Vimpat®(lacosamide tablets) |
RE38,551 |
|
UCB, Inc. v. Ranbaxy Labs. Ltd., 13-1215 (D. Del.) |
July 10, 2013 |
Hon. Leonard P. Stark |
Vimpat®(lacosamide tablets) |
RE38,551 |
|
UCB, Inc. v. Sandoz, Inc., 13-1216 (D. Del.) |
July 10, 2013 |
Hon. Leonard P. Stark |
Vimpat®(lacosamide tablets) |
RE38,551 |
|
UCB, Inc. v. Sciegen Pharma., Inc., 13-1217 (D. Del.) |
July 10, 2013 |
Hon. Leonard P. Stark |
Vimpat®(lacosamide tablets) |
RE38,551 |
|
UCB, Inc. v. Sun Pharma Global FZE, 13-1218 (D. Del.) |
July 10, 2013 |
Hon. Leonard P. Stark |
Vimpat®(lacosamide tablets) |
RE38,551 |
|
UCB, Inc. v. Watson Labs., Inc.--Florida, 13-1219 (D. Del.) |
July 10, 2013 |
Hon. Leonard P. Stark |
Vimpat®(lacosamide tablets) |
RE38,551 |
|
UCB, Inc. v. Zydus Pharma (USA), Inc., 13-1220 (D. Del.) |
July 10, 2013 |
Hon. Leonard P. Stark |
Vimpat®(lacosamide tablets) |
RE38,551 |
|
Alcon Pharma. Ltd. v. Lupin Ltd., 13-1230 (D. Del.) |
July 12, 2013 |
Hon. Sue L. Robinson |
Moxeza®(moxifloxacin hydrochloride ophthalmic solution) |
8,450,311 |
|
Cumberland Pharma. Inc. v. Akorn, Inc., 13-1232 (D. Del.) |
July 12, 2013 |
Hon. Leonard P. Stark |
Acetadote®(acetylcysteine injection) |
8,148,356 |
|
Aptalis Pharma US Inc. v. Sandoz Inc., 13-4290 (D.N.J.) |
July 12, 2013 |
Hon. Mary L. Cooper |
Canasa®(mesalamine rectal suppository) |
8,217,083 8,436,051 |
|
Abbvie, Inc. v. Roxane Labs., Inc., 13-0708 (S.D. Ohio) |
July 18, 2013 |
Hon. Edmund A. Sargus |
Norvir® |
8,268,349 8,399,015 |
|
Merck & CIE v. Watson Labs., Inc., 13-1272 (D. Del.) |
July 23, 2013 |
Hon. Richard G. Andrews |
Beyaz®(drospirenone / ethinyl estradiol / levomefolate calcium tablets) |
6,441,168 |
|
Merck & CIE v. Watson Labs., Inc., 13-1309 (D. Nev.) |
July 23, 2013 |
Hon. James C. Mahan |
Beyaz®(drospirenone / ethinyl estradiol / levomefolate calcium tablets) |
6,441,168 |
|
Cornerstone Therapeutics Inc. v. Exela Pharma Sciences, LLC, 13-1275 (D. Del.) |
July 24, 2013 |
Hon. Gregory M. Sleet |
Cardene®(nicardipine hydrochloride premixed injection) |
7,612,102 7,659,291 |
|
Eisai Co., Ltd. v. Glenmark Pharma., Ltd., 13-1279 (D. Del.) |
July 24, 2013 |
Hon. Leonard P. Stark |
Banzel®(rufinamide tablets) |
6,740,669 7,750,028 8,076,362 |
|
Eisai Co., Ltd. v. Hetero Labs Ltd., 13-1280 (D. Del.) |
July 24, 2013 |
Hon. Leonard P. Stark |
Banzel®(rufinamide tablets) |
6,740,669 7,750,028 8,076,362 |
|
Eisai Co., Ltd. v. Lupin Ltd., 13-1281 (D. Del.) |
July 24, 2013 |
Hon. Leonard P. Stark |
Banzel®(rufinamide tablets) |
6,740,669 7,750,028 8,076,362 |
|
Eisai Co., Ltd. v. Mylan Pharma. Inc., 13-1282 (D. Del.) |
July 24, 2013 |
Hon. Leonard P. Stark |
Banzel®(rufinamide tablets) |
6,740,669 7,750,028 8,076,362 |
|
Eisai Co., Ltd. v. Roxane Labs., Inc., 13-1284 (D. Del.) |
July 24, 2013 |
Hon. Leonard P. Stark |
Banzel®(rufinamide tablets) |
6,740,669 7,750,028 8,076,362 |
|
Janssen Pharma., Inc. v. Actavis Elizabeth LLC, 13-4507 (D.N.J.) |
July 25, 2013 |
Hon. Claire C. Cecchi |
Nucynta®and Nucynta®ER (tapentadol hydrochloride extended-release tablets) |
RE39,593 7,994,364 8,309,060 |
|
Alcon Research, Ltd. v. Mylan Pharma. Inc., 13-1332 (D. Del.) |
July 26, 2013 |
Hon. Sue L. Robinson |
Travatan Z®(travoprost ophthalmic solution) |
8,268,299 8,323,630 8,388,941 |
|
Depomed, Inc. v. Banner Pharmacaps Inc., 13-4542 (D.N.J.) |
July 26, 2013 |
Hon. Jose L. Linares |
Zipsor®(diclofenac potassium capsules) |
6,365,180 7,662,858 7,884,095 7,939,518 8,110,606 |
|
UCB, Inc. v. Sun Pharma Global FZE, 13-5514 (N.D. Ill.) |
Aug. 1, 2013 |
Hon. Amy J. St. Eve |
Vimpat®(lacosamide tablets) |
RE38,551 |
|
Pfizer Inc. v. Wockhardt Bio AG, 13-1387 (D. Del.) |
Aug. 2, 2013 |
Hon. Gregory M. Sleet |
Toviaz®(fesoterodine fumarate extended-release tablets) |
6,858,650 7,384,980 7,855,230 7,985,772 8,338,478 |
|
Novartis Pharma. Corp. v. Hospira, Inc., 13-4669 (D.N.J.) |
Aug. 2, 2013 |
Hon. Susan D. Wigenton |
Zometa®(zoledronic acid) |
7,932,241 8,324,189 |
|
Supernus Pharma., Inc. v. Actavis Inc., 13-4740 (D.N.J.) |
Aug. 7, 2013 |
Hon. Renee M. Bumb |
Oxtellar XR®(oxcarbazepine extended-release tablets) |
7,722,898 7,910,131 |
|
Depomed, Inc. v. Banner Pharmacaps Inc., 13-0653 (M.D.N.C.) |
Aug. 9, 2013 |
Hon. James A. Beaty, Jr. |
Zipsor®(diclofenac potassium capsules) |
6,365,180 7,662,858 7,884,095 7,939,518 8,110,606 |
|
AstraZeneca AB v. Wockhardt Ltd., 13-4854 (D.N.J.) |
Aug. 12, 2013 |
Hon. Joel A. Pisano |
Nexium®(esomeprazole magnesium delayed-release oral capsules) |
5,714,504 5,877,192 6,875,872 |
|
Novo Nordisk Inc. v. Amneal Pharma., LLC, 13-4915 (D.N.J.) |
Aug. 14, 2013 |
Hon. Michael A. Shipp |
Vagifem®(estradiol vaginal tablets) |
7,018,992 |
|
Teva Branded Pharma. Products R&D, Inc. v. Perrigo Pharma. Co., 13-1441 (D. Del.) |
Aug. 16, 2013 |
Hon. Gregory M. Sleet |
ProAir®HFA (albuterol sulfate inhalation aerosol) |
7,105,152 7,566,445 6,446,627 8,132,712 |
|
Reckitt Benckiser Pharma., Inc. v. Par Pharma., Inc., 13-1461 (D. Del.) |
Aug. 20, 2013 |
Hon. Richard G. Andrews |
Suboxone®(buprenorphine hydrochloride / naloxone hydrochloride sublingual film) |
8,475,832 8,017,150 |
|
Purdue Pharma. Products L.P. v. TWI Pharma, Inc., 13-5003 (D.N.J.) |
Aug. 20, 2013 |
Hon. Jose L. Linares |
Intermezzo®(zolpidem tartrate sublingual tablets) |
8,242,131 8,252,809 |
|
Novartis Pharma. Corp. v. Par Pharma., Inc., 13-1467 (D. Del.) |
Aug. 22, 2013 |
Hon. Richard G. Andrews |
Exelon®Patch (rivastigmine transdermal system or extended release film) |
6,335,031 |
|
Purdue Pharma. Products L.P. v. TWI Pharma, Inc., 13-5999 (N.D. Ill.) |
Aug. 22, 2013 |
Hon. Thomas M. Durkin |
Intermezzo®(zolpidem tartrate sublingual tablets) |
8,242,131 8,252,809 |
|
Intelgenx Corp. v. Wockhardt Bio, AG, 13-5074 (D.N.J.) |
Aug. 23, 2013 |
Hon. William J. Martini |
Forfivo XL®(bupropion hydrochloride extended-release tablets) |
7,674,479 |
|
Horizon Pharma AG v. Watson Labs., Inc.—Florida, 13-5124 (D.N.J.) |
Aug. 26, 2013 |
Hon. Joseph E. Irenas |
Rayos®(prednisone delayed-release tablets) |
6,488,960 6,677,326 8,309,124 8,168,218 8,394,407 |
|
Novartis Pharma. Corp. v. Akorn, Inc., 13-5125 |
Aug. 26, 2013 |
Hon. Susan D. Wigenton |
Zometa®(zoledronic acid for injection) Reclast® (zoledronic acid for injection) |
7,932,241 9,052,987 8,324,189 |
|
Horizon Pharma AG v. Watson Labs., Inc.—Florida, 13-61868 (S.D. Fl.) |
Aug. 28, 2013 |
Hon. Robert N. Scola, Jr. |
Rayos®(prednisone delayed-release tablets) |
6,488,960 6,677,326 8,309,124 8,168,218 8,394,407 |
|
Takeda Pharma. Co., Ltd. v. Mylan, Inc., 13-4001 (N.D. Cal.) |
Aug. 28, 2013 |
Hon. Nathanael M. Cousins |
Dexilant®(dexlansoprazole capsules) |
8,173,158 8,173,187 |
|
Takeda Pharma. Co., Ltd. v. Mylan, Inc., 13-4002 (N.D. Cal.) |
Aug. 28, 2013 |
Hon. Nathanael M. Cousins |
Dexilant®(dexlansoprazole capsules) |
6,462,058 6,664,276 6,939,971 7,285,668 7,790,755 |
|
Senju Pharma. Co., Ltd. v. Akorn, Inc., 13-6080 (S.D.N.Y.) |
Aug. 28, 2013 |
Hon. Paul A. Crotty |
Istalol® |
6,335,335
|
|
Genzyme Corp. v. Dr. Reddy’s Labs., Ltd., 13-1506 (D. Del.) |
Aug. 29, 2013 |
Hon. Gregory M. Sleet |
Mozobil®(plerixafor solution for injection) |
RE42,152 7,897,590 6,987,102 |
|
Genzyme Corp. v. Sandoz, Inc., 13-1507 (D. Del.) |
Aug. 29, 2013 |
Hon. Gregory M. Sleet |
Mozobil®(plerixafor solution for injection) |
RE42,152 7,897,590 6,987,102 |
|
Genzyme Corp. v. Teva Pharma. USA, Inc., 13-1508 (D. Del.) |
Aug. 29, 2013 |
Hon. Gregory M. Sleet |
Mozobil®(plerixafor solution for injection) |
RE42,152 7,897,590 6,987,102 |
|
Takeda Pharma. Co., Ltd. v. Mylan, Inc., 13-0197 (N.D.W.V.) |
Aug. 29, 2013 |
Hon. Irene M. Keeley |
Dexilant®(dexlansoprazole capsules) |
6,462,058 6,664,276 6,939,971 7,285,668 7,790,755 8,173,158 8,173,187 |
|
Takeda Pharma. USA, Inc. v. Par Pharma. Companies, Inc., 13-1524 (D. Del.) |
Aug. 30, 2013 |
Hon. Sue L. Robinson |
Colcrys®(colchicine tablets) |
7,906,519 7,935,731 8,093,298 7,964,648 8,093,297 |
|
Roche Palo Alto LLC v. Mylan Pharma. Inc., 13-1532 (D. Del.) |
Sept. 4, 2013 |
Hon. Gregory M. Sleet |
Valcyte®(valganciclovir hydrochloride tablets) |
6,083,953 |
|
Roche Palo Alto LLC v. Watson Labs., Inc.—Florida, 13-1533 (D. Del.) |
Sept. 4, 2013 |
Hon. Gregory M. Sleet |
Valcyte®(valganciclovir hydrochloride tablets) |
6,083,953 |
|
Ferring B.V. v. Actavis, Inc., 13-0477 (D. Nev.) |
Sept. 6, 2013 |
Hon. Larry R. Hicks |
Lysteda®(tranexamic acid tablets) |
8,487,005 7,947,739 8,022,106 8,273,795 |
|
Alkem Labs. Ltd. v. NPS Pharma., Inc., 13-6487 (N.D. Ill.) |
Sept. 10, 2013 |
Hon. Edmond E. Chang |
Nucynta ER®(tapentadol extended-release tablets) |
6,071,970 |
|
Merck, Sharp & Dohme Corp. v. Aurobindo Pharma Ltd., 13-5442 (D.N.J.) |
Sept. 11, 2013 |
Hon. Jerome B. Simandle |
Sustiva®(efavirenz tablets) |
6,639,071 6,939,964 6,673,372 |
|
Jazz Pharma., Inc. v. Amneal Pharma., LLC, 13-5450 (D.N.J.) |
Sept. 12, 2013 |
Hon. Esther Salas |
Xyrem® |
8,457,988 8,461,203 |
|
Alcon Research, Ltd. v. Wockhardt Ltd., 13-1452 (S.D. Ind.) |
Sept. 12, 2013 |
Hon. Sarah Evans Barker |
Pataday®(olopatadine hydrochloride ophthalmic solution) |
6,995,186 7,402,609 |
|
AbbVie Inc. v. Hikma Pharma. Co., Ltd., 13-1557 (D. Del.) |
Sept. 13, 2013 |
Hon. Gregory M. Sleet |
Zemplar®(paricalcitol injectable) |
5,597,815 |
|
Eli Lilly and Co. v. Sun Pharma Indus. Ltd., 13-1469 (S.D. Ind.) |
Sept. 13, 2013 |
Hon. Tonya Walton Pratt |
Alimta®(pemetrexed injectable) |
7,772,209 |
|
Senju Pharma Co., Ltd. v. Sandoz Inc., 13-6608 (S.D.N.Y.) |
Sept. 18, 2013 |
Hon. Paul A. Crotty |
Istalol® |
6,335,335 6,645,963 |
|
Forest Labs., Inc. v. Apotex Corp., 13-1602 (D. Del.) |
Sept. 23, 2013 |
Hon. Sue L. Robinson |
Savella®(milnacipran hydrochloride tablets) |
6,602,911 7,888,342 7,994,220 |
|
Forest Labs., Inc. v. Hetero USA Inc., 13-1603 (D. Del.) |
Sept. 23, 2013 |
Hon. Sue L. Robinson |
Savella®(milnacipran hydrochloride tablets) |
6,602,911 7,888,342 7,994,220 |
|
Forest Labs., Inc. v. Lupin Ltd., 13-1604 (D. Del.) |
Sept. 23, 2013 |
Hon. Sue L. Robinson |
Savella®(milnacipran hydrochloride tablets) |
6,602,911 7,888,342 7,994,220 |
|
Forest Labs., Inc. v. Mylan Inc., 13-1605 (D. Del.) |
Sept. 23, 2013 |
Hon. Sue L. Robinson |
Savella®(milnacipran hydrochloride tablets) |
6,602,911 7,888,342 7,994,220 |
|
Forest Labs., Inc. v. Par Pharma. Inc., 13-1606 (D. Del.) |
Sept. 23, 2013 |
Hon. Sue L. Robinson |
Savella®(milnacipran hydrochloride tablets) |
6,602,911 7,888,342 7,994,220 |
|
Forest Labs., Inc. v. Ranbaxy Inc., 13-1607 (D. Del.) |
Sept. 23, 2013 |
Hon. Sue L. Robinson |
Savella®(milnacipran hydrochloride tablets) |
6,602,911 7,888,342 7,994,220 |
|
Pfizer Inc. v. Apotex Inc., 13-6962 (N.D. Ill.) |
Sept. 27, 2013 |
Hon. Marvin E. Aspen |
Tygacil®(tigecycline injectable IV infusion) |
8,372,995 |
|
Otsuka Pharma. Co., Ltd. v. Sandoz, Inc. 13-5788 (D.N.J.) |
Sept. 27, 2013 |
Hon. Freda L. Wolfson |
Busulfex®(busulfan injection) |
5,430,057 5,559,148 |
|
Galderma Labs., L.P. v. Perrigo Israel Pharma. Ltd., 13-3930 (N.D. Tex.) |
Sept. 27, 2013 |
Hon. David C Godbey |
Epiduo®Gel (adapalene / benzoyl peroxide) |
7,820,186 7,964,202 8,071,644 8,080,537 8,105,618 8,129,362 8,241,649 8,445,543 |
|
Helsinn Healthcare, S.A. v. Dr. Reddy’s Labs., Ltd., 13-5815 (D.N.J.) |
Sept. 30, 2013 |
Hon. Mary L. Cooper |
Aloxi®(palonosetron hydrochloride injection) |
8,518,981 |
